McLean, VA, United States of America

Paul Zarek

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Paul Zarek

Introduction

Paul Zarek is a notable inventor based in McLean, Virginia. He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in the modulation of T cell responses, which has important implications for immune response management.

Latest Patents

Zarek holds a patent for "Adenosine receptor agonists and antagonists to modulate T cell responses." This patent describes the uses of A2a adenosine receptor antagonists and agonists to provide long-term modulation of immune responses. Specifically, A2a receptor antagonists are designed to enhance immune responses by reducing T-cell mediated tolerance to antigenic stimuli. Conversely, agonists are provided to enhance the effectiveness of immunosuppressive agents. The application outlines methods of treatment and prevention based on the long-term effects of these compounds on T cell responses.

Career Highlights

Paul Zarek is affiliated with The Johns Hopkins University, where he continues to advance his research in immunology. His work has garnered attention for its potential to improve therapeutic strategies in treating various immune-related conditions.

Collaborations

Zarek has collaborated with esteemed colleagues such as Jonathan David Powell and Charles George Drake. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Paul Zarek's innovative work in the modulation of T cell responses through his patented research represents a significant advancement in immunology. His contributions have the potential to influence future treatments and improve patient outcomes in immune response management.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…